FDA Warns of Itching Risks with Popular Allergy Medications
Seasonal allergies are triggered by pollen and blooming flowers and other plants. Allergy symptoms include runny noses, itchy eyes, sneezing, and sometimes coughing. Patients have been prescribed medications, and in some cases, take over-the-counter allergy medication. Recently, the U.S. Food and Drug Administration (FDA) warned the public that when patients stop long-term use of Zyrtec or Xyzal, oral allergy medications, may experience rare but severe itching. If you or your child suffered severe adverse effects from Zyrtec, Xyzal or another allergy medication, you should call the experienced Chicago-based product liability attorneys of the Moll Law Firm about whether you have a case against the manufacturer or others in the chain of distribution.
Call Moll Law Group About Your Claim
Cetirizine (Zyrtec) and levocetirizine (Xyzal) are antihistamines, which are mobilized to stop histamines released during people’s allergic responses to seasonal allergens like pollen and grass. The former was approved in 1995 and became an over-the-counter medicine in 2008. The latter was approved for prescriptions in 2007 and was made an over-the-counter drug in 2017.
The American College of Allergy, Asthma and Immunology has cited information from the Centers for Disease Control and Prevention (CDC) that indicates about 1 out of 3 adults and 1 out of 4 children in the United States have reported their food allergy, eczema, or seasonal allergy. Over 100 million people in the country have stated they have allergy symptoms. The FDA’s public warning noted that people purchased over 80 million packs of popular allergy medications in 2022.